Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.

Published

Journal Article

Recent advances now permit resection of many pharyngeal tumors through the open mouth, an approach that can greatly reduce the morbidity of surgical exposure. These transoral techniques are being rapidly adopted by the surgical community and hold considerable promise. On November 6-7, 2011, the National Cancer Institute sponsored a Clinical Trials Planning Meeting to address how to further investigate the use of transoral surgery, both in the good prognosis human papillomavirus (HPV)-initiated oropharyngeal cancers, and in those with HPV-unrelated disease. The proceedings of this meeting are summarized.

Full Text

Duke Authors

Cited Authors

  • Adelstein, DJ; Ridge, JA; Brizel, DM; Holsinger, FC; Haughey, BH; O'Sullivan, B; Genden, EM; Beitler, JJ; Weinstein, GS; Quon, H; Chepeha, DB; Ferris, RL; Weber, RS; Movsas, B; Waldron, J; Lowe, V; Ramsey, S; Manola, J; Yueh, B; Carey, TE; Bekelman, JE; Konski, AA; Moore, E; Forastiere, A; Schuller, DE; Lynn, J; Ullmann, CD

Published Date

  • December 2012

Published In

Volume / Issue

  • 34 / 12

Start / End Page

  • 1681 - 1703

PubMed ID

  • 23015475

Pubmed Central ID

  • 23015475

Electronic International Standard Serial Number (EISSN)

  • 1097-0347

Digital Object Identifier (DOI)

  • 10.1002/hed.23136

Language

  • eng

Conference Location

  • United States